Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Athersys Inc (ATHX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 274,388
  • Shares Outstanding, K 138,580
  • Annual Sales, $ 3,710 K
  • Annual Income, $ -32,240 K
  • 36-Month Beta -0.75
  • Price/Sales 72.88
  • Price/Cash Flow N/A
  • Price/Book 4.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.85 +5.15%
on 08/06/18
2.16 -10.19%
on 07/20/18
-0.08 (-3.96%)
since 07/17/18
3-Month
1.85 +5.15%
on 08/06/18
3.09 -37.22%
on 06/07/18
-0.49 (-20.16%)
since 05/17/18
52-Week
1.29 +50.39%
on 03/02/18
3.09 -37.22%
on 06/07/18
+0.29 (+17.58%)
since 08/17/17

Most Recent Stories

More News
Is Athersys (ATHX) Stock Outpacing Its Medical Peers This Year?

Is (ATHX) Outperforming Other Medical Stocks This Year?

ATHX : 1.94 (-2.02%)
Recent Analysis Shows Williams Partners, GameStop, Opko Health, Athersys, CSX, and Kratos Defense & Security Solutions Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Williams Partners L.P. (NYSE:WPZ),...

WPZ : 47.37 (-0.38%)
CSX : 73.69 (+0.34%)
OPK : 5.61 (+2.19%)
ATHX : 1.94 (-2.02%)
GME : 15.33 (+0.72%)
KTOS : 12.92 (+1.73%)
The Growth of Stem Cell Applications are Contributing to the Cell Therapy Processing Market

According to a report published by BCC Research, the cell therapy processing market is expected to reach USD 5 Billion by 2022 while growing at a compound annual growth rate of 30.9% during forecast year....

SRNE : 5.35 (+0.94%)
SNDX : 7.18 (-1.24%)
ZIOP : 2.86 (+6.32%)
ATHX : 1.94 (-2.02%)
AVCO : 2.7500 (+1.85%)
Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy

Athersys, Inc. (NASDAQ: ATHX) announced the addition of an experienced manufacturing executive to oversee manufacturing operations and help plan for and lead the Company's transition into commercial manufacturing...

ATHX : 1.94 (-2.02%)
Athersys Announces Enrollment of First Patient in Masters-2 Phase 3 Study of Multistem(R) Treatment for Ischemic Stroke

Pivotal study has received a Special Protocol Assessment (SPA), Fast Track Designation, and Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA)

ATHX : 1.94 (-2.02%)
Biotechnology Companies Involved in Regenerative Medicine

HENDERSON, NV / ACCESSWIRE / July 12, 2018 / The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. With that...

ATHX : 1.94 (-2.02%)
Stem Cell Companies Innovating for the Future

FN Media Group Presents Microcapspeculators.com News Commentary

SGMO : 15.35 (-0.65%)
BRTX : 1.9500 (+4.84%)
VCEL : 11.10 (-3.48%)
FATE : 11.20 (+1.27%)
ATHX : 1.94 (-2.02%)
Rise of Chronic Diseases Leads to Growing Investment in Stem Cell Research

According to a report published by Transparency Market Research, the global stem cell market is expected to reach US 270.5 Billion by 2025, while increasing at a compound annual growth rate of 13.8% during...

SGMO : 15.35 (-0.65%)
ISCO : 1.5700 (+3.29%)
CBMG : 19.15 (-0.26%)
VCEL : 11.10 (-3.48%)
ATHX : 1.94 (-2.02%)
Athersys to Host Second Quarter Financial Results Call

Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7, 2018, and will host a conference call shortly thereafter...

ATHX : 1.94 (-2.02%)
4 Biotech Stocks to Bet on in the Second Half of 2018

While the first half did not turn out to be great for the biotech sector, the second half is expected to be much better. Here, we list four biotechs poised for a good run.

AGLE : 9.20 (-0.22%)
CELG : 90.37 (+0.24%)
GILD : 72.92 (-3.53%)
CLSN : 2.53 (-0.78%)
AMGN : 197.42 (+0.50%)
ATHX : 1.94 (-2.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ATHX with:

Business Summary

Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company's lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the...

See More

Key Turning Points

2nd Resistance Point 2.03
1st Resistance Point 1.98
Last Price 1.94
1st Support Level 1.90
2nd Support Level 1.87

See More

52-Week High 3.09
Fibonacci 61.8% 2.40
Fibonacci 50% 2.19
Fibonacci 38.2% 1.98
Last Price 1.94
52-Week Low 1.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar